{"transactions":[{"id":1863587,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112609,"kind":"person","name":"Ellis Ronald J. Jr.","position":1,"cik":"0001790670","reported_name":"Ellis Ronald J. Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2023-06-08T01:20:41.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":1162,"price":37.865,"value":43999.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":30909,"source":{"system":"sec-edgar","filing":"0001209191-23-035255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919123035255/doc4.xml","form_type":"4"}},{"id":1863586,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112609,"kind":"person","name":"Ellis Ronald J. Jr.","position":1,"cik":"0001790670","reported_name":"Ellis Ronald J. Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2023-06-08T01:20:41.000Z","date":"2023-06-06","kind":"sale","planned":false,"acquired":false,"shares":1114,"price":38.991,"value":43435.974,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":32071,"source":{"system":"sec-edgar","filing":"0001209191-23-035255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919123035255/doc4.xml","form_type":"4"}},{"id":3372580,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":112609,"kind":"person","name":"Ellis Ronald J. Jr.","position":1,"cik":"0001790670","reported_name":"Ellis Ronald J. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX","position":2,"cik":"0001396814","reported_name":"Pacira BioSciences, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-11-14T02:06:16.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":14329052,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Pacira BioSciences, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":580357},"source":{"system":"sec-edgar","filing":"0001192482-19-000432","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000119248219000432/edgar.xml","form_type":"4"}},{"id":3372579,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":112609,"kind":"person","name":"Ellis Ronald J. Jr.","position":1,"cik":"0001790670","reported_name":"Ellis Ronald J. Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX","position":2,"cik":"0001396814","reported_name":"Pacira BioSciences, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T02:06:16.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":580357,"ownership":{"direct":false,"nature":"By Pacira BioSciences, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects 193,699 shares of common stock received as a payment-in-kind dividend on Series B Preferred Stock exempt from reporting under Rule 16a-9(a)."}],"balance_after":774056,"source":{"system":"sec-edgar","filing":"0001192482-19-000432","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000119248219000432/edgar.xml","form_type":"4"}}]}